ZINAXIN JOINT CARE  INFORMATION

Arthritis is the single greatest cause of disability. There is a 1 in 10 chance of being affected by some form of arthritis at some stage in your life. It affects both young and old. There are over 100 different forms.

Ginger has been used by the Chinese in the treatment of various problems, ie. pain and inflammatory conditions including arthritis, since more than 2,500 years. Ginger is also used in other Asiatic countries in the treatment of muscle and joint problems.

Zinaxin complements traditional pharmaceutical treatments. It contains two types of ginger extracted by a patented process and guarantees 100% uniform active compounds.

Zinaxin can be an effective alternative to traditional pharmaceutical treatments. It is a completely natural product and has a low adverse event profile.

Zinaxin is the result of years of research concentrating on inflammatory processes. Experimental work was carried out in Denmark at the Copenhagen Science Park, the Institute for Medical Physiology and the Department of Clinical Microbiology.

Zinaxin uses a technologically advanced and patented extraction method, which is far superior to other methods. Zinaxin is absorbed much faster and reaches a higher level in the blood than any other product, which is maintained for a longer period of time.

Zinaxin is a natural herbal extract rather than a drug. It takes effect normally after 3-28 days.

RECOMMENDED DAILY DOSAGE

2 capsules per day in divided doses with liquid and food for the first month.

1-2 capsules daily with food as required on an on-going basis or as directed by your health professional.

Each capsule containes extract equivalent to Dry Zingiber officinalis rhizome 150 mg, Alpinia Galanga rhizome 660 mg.

BACK TO PREVIOUS PAGE

A1Health

E-Mail: a1health@ctsserver.com

Copyright 1999-2005 © A1Health. All Rights reserved

The contents of this web page are owned by A1Health and shall not be copied, duplicated, replicated, imitated, reproduced, or otherwise used without the express written consent of A1Health. .

.

.

.

.